Navigation Links
Researchers find Clostridium difficile is more common than MRSA in southeast community hospitals
Date:3/21/2010

Atlanta, Ga. (March 22, 2010)-- Researchers studying epidemiology of healthcare-associated infections (HAIs) in community hospitals in the southeast U.S. found that rates of Clostridium difficile infections (CDI) surpassed infection rates for methicillin-resistant Staphylococcus aureus (MRSA). Scientists also discovered that healthcare-associated CDI, which is a bacterium that causes diarrhea and more serious intestinal conditions such as colitis, occurs more often (21 percent) than healthcare-associated infections due to MRSA. In addition, healthcare-associated CDI occurs approximately as often as healthcare-associated bloodstream infections and combined device-related infections.

"Despite the amount of attention given to MRSA, our study shows that CDI has emerged as the leading healthcare-associated infection in our network of hospitals," said Becky Miller, MD, Duke Infection Control Outreach Network, Duke University. "In addition, our study likely underestimates the true scope of the problem since we did not include cases of community-onset healthcare-associated CDI."

This is the first large study to use patient level surveillance data (i.e. numerators and denominators) to compare the rates of healthcare-associated CDI and MRSA. The study was presented today at the Fifth Decennial International Conference on Healthcare-Associated Infections. Previous studies were based on estimates using hospital ICD-9-CM discharge diagnosis codes.

Dr. Miller and her colleagues studied 30 community hospitals in the Southeastern United States which are members of the Duke Infection Control Outreach Network (DICON). Over the 18-month period, which included more than 2 million patient days, researchers compared 607 cases of CDI and 508 cases of infections due to MRSA.

To better understand and identify infection trends, researchers also examined 949 other cases of HAIs. They found bloodstream infections occurred in 481 patients on general hospital wards and device-related infections occurred in 468 patients in intensive care units (ICU). ICU device-related infections included 197 catheter-associated urinary tract infections, 102 ventilator-associated pneumonias and 182 catheter-associated bloodstream infections.

"These findings are a reminder that prevention priorities must include the prevention of CDI", said Dr. Denise Cardo, director of CDC's Division of Healthcare Quality and Promotion. "CDI is an important cause of healthcare-associated infections and deserves attention."

Dr. Miller noted that additional epidemiologic studies are needed to determine whether prescribing practices, geographic differences, hospital characteristics, or other factors affected infection rates found in this study.


'/>"/>

Contact: Sharon Reis
sreis@gymr.com
202-745-5103
Society for Healthcare Epidemiology of America
Source:Eurekalert

Related biology news :

1. Einstein researchers discover 2 new ways to kill TB
2. USC researchers identify key mechanism that guides cells to form heart tissue
3. Frogs, foam and fuel: University of Cincinnati researchers convert solar energy to sugars
4. U-M researchers solve a molecular mystery in muscle
5. Researchers introducing sustainable agriculture practices to improve food security
6. Carnegie Mellon researchers seek to control blood loss
7. Researchers characterize stem cell function
8. Penn researchers identify immune cells that fight parasites may promote allergies and asthma
9. VAI researchers develop tool to help study prostate cancer
10. Researchers examine plants ability to identify, block invading bacteria
11. Community involvement important in fight against childhood obesity, according to UTHealth researchers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/3/2017)...  Texas Biomedical Research Institute announced that its Board of ... as the Institute,s new President and CEO. Dr. Schlesinger will ... He is currently the Chair of the Department of Microbial ... Interface Biology at Ohio State University. "We are ... CEO of Texas Biomed," said Dr. James O. Rubin ...
(Date:2/2/2017)... 2017   TapImmune, Inc. (NASDAQ: ... in the development of innovative peptide and gene-based ... and metastatic disease, announced today it has successfully ... a second clinical lot of TPIV 200, the ... The manufactured vaccine product will be used to ...
(Date:2/2/2017)... , Feb. 1, 2017  Central to ... and meaningful advances worldwide, The Japan Prize Foundation ... Prize, who have pushed the envelope in their ... and Communication. Three scientists are being recognized with ... achievements that not only contribute to the advancement ...
Breaking Biology News(10 mins):
(Date:2/21/2017)... 2017 /PRNewswire/ - SQI Diagnostics Inc. ("SQI" or the "Company") (TSX-V: ... the three months ended December 31, 2016. ... and diagnostics company that develops and commercializes proprietary technologies and ... ... the commercial milestones achieved in fiscal 2016," said Andrew ...
(Date:2/21/2017)... ... 21, 2017 , ... Genedata, a leading provider of advanced ... establishment of Genedata Limited as a new subsidiary in the United Kingdom. The ... science informatics. Creating the UK subsidiary reinforces Genedata’s commitment to collaborate closely with ...
(Date:2/21/2017)... IL (PRWEB) , ... February ... ... of the Life -Sciences division, Treximo will pair its $200M operational capacity ... results-based consulting and project management in areas affecting quality and operational management. ...
(Date:2/21/2017)... VANCOUVER, British Columbia , Feb. 21, 2017 /PRNewswire/ ... that apatorsen results from two randomized Phase 2 clinical trials ... 2017 Genitourinary Cancers Symposium, held February 16 th - 18 ... from trials in bladder and prostate cancers demonstrated apatorsen was ... standard-of-care treatments. ...
Breaking Biology Technology: